HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CHP-HER2 vaccine

truncated 146HER2 complexed with cholesteryl pullulan; elicits CD8+ and CD4+ T-cell immune response

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Cancer Vaccines: 4052
      - CHP-HER2 vaccine: 1

Experts

1.	Akiyoshi, Kazunari: 1 article (03/2008)
2.	Hirayama, Michiko: 1 article (03/2008)
3.	Hoffman, Eric W: 1 article (03/2008)
4.	Imai, Hiroshi: 1 article (03/2008)
5.	Kageyama, Shinichi: 1 article (03/2008)
6.	Katayama, Naoyuki: 1 article (03/2008)
7.	Kitano, Shigehisa: 1 article (03/2008)
8.	Murphy, Roger: 1 article (03/2008)
9.	Nagata, Yasuhiro: 1 article (03/2008)
10.	Old, Lloyd J: 1 article (03/2008)

Related Diseases

1.	Neoplasms (Cancer) 03/01/2008 - "The CHP-HER2 vaccine, comprising truncated 146HER2 protein complexed with nanogels of cholesteryl pullulan (CHP), is a novel protein antigen vaccine that elicits 146HER2-specific CD8(+) and CD4(+) T-cell immune responses in patients with HER2-expressing tumors. "

Related Drugs and Biologics

1.	Vaccines
2.	Proteins (Proteins, Gene)
3.	Antigens
4.	Nanogels
5.	pullulan